Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,244) Arrow Down
Filter Results: (1,244) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,244)
    • People  (5)
    • News  (171)
    • Research  (928)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (756)

Show Results For

  • All HBS Web  (1,244)
    • People  (5)
    • News  (171)
    • Research  (928)
    • Events  (6)
    • Multimedia  (12)
  • Faculty Publications  (756)
← Page 38 of 1,244 Results →
  • February 2001 (Revised July 2006)
  • Case

Discovering the Future: R&D Strategy at Merck

By: Gary P. Pisano
Given explosive growth in technologies for drug discovery, how does Merck remain competitive in an industry that is fragmented and continues to consolidate? View Details
Keywords: Competitive Strategy; Research and Development; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Pisano, Gary P. "Discovering the Future: R&D Strategy at Merck." Harvard Business School Case 601-086, February 2001. (Revised July 2006.)
  • May 1987
  • Teaching Note

Eli Lilly and Co. (A) and (B), Teaching Note

By: William J. Bruns Jr.
Keywords: Pharmaceutical Industry
Citation
Related
Bruns, William J., Jr. "Eli Lilly and Co. (A) and (B), Teaching Note." Harvard Business School Teaching Note 187-186, May 1987.
  • June 1999 (Revised October 1999)
  • Case

Eli Lilly, 1998 (A): Strategic Challenges

By: Michael Y. Yoshino and Thomas W. Malnight
Deals with key strategic challenges facing Eli Lilly, a highly successful U.S.-based drug company. View Details
Keywords: Problems and Challenges; Strategy; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Yoshino, Michael Y., and Thomas W. Malnight. "Eli Lilly, 1998 (A): Strategic Challenges." Harvard Business School Case 399-173, June 1999. (Revised October 1999.)
  • June 1998
  • Supplement

MBA Integrative Exercise: Competition & Strategy, April 1998 , Video

By: Carin-Isabel Knoop
Daniel Vasella, President of Novartis AG, discusses the situation in Indonesia and his ideas of what Suharto should do in the spring of 1998. Drummond Paris, Regional Pharma Head Asia/Pacific, Novartis AG, discusses the opportunities for Novartis in Indonesia and also... View Details
Keywords: Competitive Strategy; Pharmaceutical Industry; Indonesia
Citation
Purchase
Related
Knoop, Carin-Isabel. "MBA Integrative Exercise: Competition & Strategy, April 1998 , Video." Harvard Business School Video Supplement 898-504, June 1998.
  • March 1993
  • Supplement

Burroughs Wellcome and AZT (C)

By: Willis M. Emmons III
Describes key developments relating to Burroughs Wellcome, AZT and other AIDS drugs, and the AIDS issue in general from late 1989 through 1992. Includes excerpts from Wellcome PLC's financial statements and updated statistics on AIDS in the United States. View Details
Keywords: Health Pandemics; Multinational Firms and Management; Financial Statements; Pharmaceutical Industry; United States
Citation
Purchase
Related
Emmons, Willis M., III. "Burroughs Wellcome and AZT (C)." Harvard Business School Supplement 793-115, March 1993.
  • March 1993
  • Supplement

Burroughs Wellcome and AZT (B)

By: Willis M. Emmons III
Describes Burroughs Wellcome's response to protests over the pricing of its AIDS drug AZT in September 1989. Also presents short-term reactions by government officials, AIDS activists, and investors to Burroughs Wellcome's strategy. View Details
Keywords: Ethics; Health Pandemics; Multinational Firms and Management; Price; Crime and Corruption; Risk and Uncertainty; Business Strategy; Business and Community Relations; Business and Government Relations; Business and Shareholder Relations; Pharmaceutical Industry
Citation
Purchase
Related
Emmons, Willis M., III. "Burroughs Wellcome and AZT (B)." Harvard Business School Supplement 793-114, March 1993.
  • March 1997
  • Teaching Note

Eli Lilly and Company: Innovation in Diabetes Care TN

By: Clayton M. Christensen and Bret J. Baird
Teaching Note for (9-696-077). View Details
Keywords: Pharmaceutical Industry
Citation
Purchase
Related
Christensen, Clayton M., and Bret J. Baird. "Eli Lilly and Company: Innovation in Diabetes Care TN." Harvard Business School Teaching Note 697-101, March 1997.
  • December 1998 (Revised September 1999)
  • Case

Novartis: Betting on Life Sciences

By: Ray A. Goldberg, Carin-Isabel Knoop and Srinivas Sunder
The merger of Ciba-Geigy and Sandoz produced genomic-based synergies for health care, agribusiness, and nutritional supplements. How to build on the strength of the individual divisions and provide synergies that would continue Novartis' leadership role is the question... View Details
Keywords: Mergers and Acquisitions; Business Divisions; Health Care and Treatment; Leadership; Product Positioning; Science-Based Business; Corporate Strategy; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Goldberg, Ray A., Carin-Isabel Knoop, and Srinivas Sunder. "Novartis: Betting on Life Sciences." Harvard Business School Case 599-076, December 1998. (Revised September 1999.)
  • January–February 1994
  • Article

Financial Engineering at Merck

By: Timothy A. Luehrman
Keywords: Finance; Engineering; Health; Pharmaceutical Industry
Citation
Find at Harvard
Related
Luehrman, Timothy A. "Financial Engineering at Merck." Harvard Business Review 72, no. 1 (January–February 1994): 89–99.
  • November 18 2004
  • Article

Merck's Recall of Rofecoxib: A Strategic Perspective

By: Felix Oberholzer-Gee and Noorein Inamdar
Keywords: Health; Perspective; Pharmaceutical Industry
Citation
Find at Harvard
Related
Oberholzer-Gee, Felix, and Noorein Inamdar. "Merck's Recall of Rofecoxib: A Strategic Perspective." New England Journal of Medicine 351, no. 21 (November 18 2004): 2147–2149.
  • April 1999 (Revised May 2000)
  • Case

Pilgrim Drug Company

David Thomas takes his first sales management assignment and is faced with a sales rep revolt because of a possible territory reorganization. In addition, his sales division is performing well below the national average. Rewritten version of an earlier case. View Details
Keywords: Conflict Management; Salesforce Management; Performance; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Burton, M. Diane, and Jeffrey L. Bradach. "Pilgrim Drug Company." Harvard Business School Case 499-062, April 1999. (Revised May 2000.)
  • February 26, 2003
  • Article

Consumers' Reports on the Health Effects of Direct-To-Consumer Drug Advertising

By: Joel S. Weissman, David Blumenthal, Alvin J. Silk, Kinga Zapert, Michael Newman and Robert Leitman
Keywords: Customers; Advertising; Health; Pharmaceutical Industry
Citation
Find at Harvard
Read Now
Related
Weissman, Joel S., David Blumenthal, Alvin J. Silk, Kinga Zapert, Michael Newman, and Robert Leitman. "Consumers' Reports on the Health Effects of Direct-To-Consumer Drug Advertising." Health Affairs (February 26, 2003).
  • 07 Apr 2003
  • Research & Ideas

Three Steps for Crisis Prevention

challenges, not on the hard work of winning hearts and minds, Shapiro ultimately lost his company. He was forced to sell Monsanto to Pharmacia-Upjohn, which bought it for its pharmaceutical division, valuing the agricultural biotechnology... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
  • 11 May 2020
  • Op-Ed

Immigration Policies Threaten American Competitiveness

It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World... View Details
Keywords: by William R. Kerr

    Arjun Goyal

    on the boards of Scorpion Therapeutics, Quanta Therapeutics, Alterome Therapeutics, Halda Therapeutics, Third Arc Bio, and Centessa Pharmaceuticals (NASDAQ: CNTA) and as a co-founder and director, Affini-T Therapeutics. Furthermore, he... View Details
    Keywords: Finance

      Arjun Goyal

      a director on the boards of Scorpion Therapeutics, Quanta Therapeutics, Affini-T and Centessa Pharmaceuticals (NASDAQ: CNTA) and has played key roles in Vida Venture’s investments in Homology Medicines (NASDAQ:FIXX), Pionyr... View Details
      Keywords: Biotech & Life Sciences;#43;#Healthcare;#75;#Venture Capital
      • Profile

      Rocio Parra

      Why was getting a business education important to you? As a consultant, I had the opportunity to work in a variety of industries from pharmaceuticals and medical devices to government and consumer packaged goods. Through these... View Details
      Keywords: Retail
      • Portrait Project

      Mickey Millar

      roach. Each incident left a stain on my spirit. While studying social welfare at HKS, I worked part-time so my pregnant sister wouldn't become homeless after she lost her job while on bed rest. During pharmaceutical case discussions at... View Details
      • Fast Answer

      Patent search: Product-associated patents

      face="Open Sans">  Check company website. Some companies may lists patents associated with their products on their websites.  For View Details

        Steve Cagnetta

        pharmaceutical and medical device companies. From time to time, he has represented and advised venture and angel groups on various matters. Prior to founding Company Counsel, Steve practiced at Hutchins, Wheeler & Dittmar, in Boston and... View Details
        Keywords: Legal;#19;#Digital Health;#20;#Ecommerce;#23;#Education Technology;#31;#Finance;#54;#Medical Devices & Hardware;#60;#Services;#64;#Software/App;#75;#Venture Capital;#238;#Fintech
        • ←
        • 38
        • 39
        • …
        • 62
        • 63
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.